Common Contracts

1,402,525 Shares ANI PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT

Underwriting Agreement • March 5th, 2014 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York

• Contract Type
  Underwriting Agreement
• Filed
  March 5th, 2014
• Company
  Ani Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representatives (the “Representatives”), an aggregate of 1,402,525 shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional 210,378 shares (the “Option Shares”) of Common Stock from the Company for the purpose of covering over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are collectively called the “Shares.”

Shares ECOtality, Inc. Common Stock UNDERWRITING AGREEMENT

Underwriting Agreement • June 6th, 2011 • Ecotality, Inc. • Motors & generators • California

• Contract Type
  Underwriting Agreement
• Filed
  June 6th, 2011
• Company
  Ecotality, Inc.
• Industry
  Motors & generators
• Jurisdiction
  California

Subject to the terms and conditions stated herein, ECOtality, Inc., a Nevada corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [__________] authorized but unissued shares (the “Firm Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The stockholders of the Company listed on Schedule II hereto (the “Selling Stockholders” and each a “Selling Stockholder”) have granted the Underwriters the option to purchase an aggregate of up to [___________] additional shares of Common Stock (the “Additional Shares”) as may be necessary to cover over-allotments made in connection with the offering. The Firm Shares and Additional Shares are collectively referred to as the “Shares.” Roth Capital Partners, LLC (the “Representative”) shall act as the representative of the several Underwriters.